He then adds that for older individuals, treatment may involve isometric knee exercises without the need for ACL reconstruction. “The MCL, located on the outside of the knee joint, can suffer ...
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...
A blockbuster AstraZeneca drug may now be used as an earlier treatment for mantle cell lymphoma (MCL), making it the first in its class approved as a first-line therapy for this rare and ...
and MCL treatment guidelines could reshape management strategies, with consideration given to factors such as efficacy, safety, and patient access.
AstraZeneca's BTK inhibitor Calquence has become the first drug in the class to be approved by the US FDA as a treatment for adult patients with previously untreated mantle cell lymphoma (MCL ...
in combination with bendamustine and rituximab for the treatment of adults with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback